
Good News | MiStent® Coronary Drug-Eluting Stent Approved, Offering a New Clinical Option for PCI!
Recently, MiStent® Sirolimus Eluting Absorbable Polymer Coronary Stent System, the flagship product of Mixin Medtech, a subsidiary of Kossel Group, has been successfully approved for







